ESSA Pharma Statistics

Total Valuation

ESSA Pharma has a market cap or net worth of $71.02 million. The enterprise value is -$55.41 million.

Market Cap	71.02M
Enterprise Value	-55.41M

Important Dates

The last earnings date was Tuesday, December 17, 2024, before market open.

Earnings Date	Dec 17, 2024
Ex-Dividend Date	n/a

Share Statistics

ESSA Pharma has 44.39 million shares outstanding. The number of shares has increased by 0.43% in one year.

Current Share Class	44.39M
Shares Outstanding	44.39M
Shares Change (YoY)	+0.43%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	28.72%
Float	20.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.57
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.64, with a Debt / Equity ratio of 0.00.

Current Ratio	38.64
Quick Ratio	38.45
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -21.12% and return on invested capital (ROIC) is -15.90%.

Return on Equity (ROE)	-21.12%
Return on Assets (ROA)	-15.52%
Return on Capital (ROIC)	-15.90%
Revenue Per Employee	n/a
Profits Per Employee	-$570,856
Employee Count	50
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.08% in the last 52 weeks. The beta is 1.62, so ESSA Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-75.08%
50-Day Moving Average	2.92
200-Day Moving Average	5.40
Relative Strength Index (RSI)	23.82
Average Volume (20 Days)	319,684

Short Selling Information

Short Interest	691,472
Short Previous Month	726,535
Short % of Shares Out	2.59%
Short % of Float	n/a
Short Ratio (days to cover)	0.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.42M
Pretax Income	-27.67M
Net Income	-28.54M
EBITDA	n/a
EBIT	-34.42M
Earnings Per Share (EPS)	-$0.64

Full Income Statement

Balance Sheet

The company has $126.76 million in cash and $329,260 in debt, giving a net cash position of $126.43 million or $2.85 per share.

Cash & Cash Equivalents	126.76M
Total Debt	329,260
Net Cash	126.43M
Net Cash Per Share	$2.85
Equity (Book Value)	124.61M
Book Value Per Share	2.81
Working Capital	124.26M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.72M
Capital Expenditures	n/a
Free Cash Flow	-22.72M
FCF Per Share	-$0.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ESSA Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.43%
Shareholder Yield	-0.43%
Earnings Yield	-40.19%
FCF Yield	-31.98%

Analyst Forecast

The average price target for ESSA Pharma is $2.00, which is 25.00% higher than the current price. The consensus rating is "Hold".

Price Target	$2.00
Price Target Difference	25.00%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 25, 2018. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Apr 25, 2018
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1